Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Jonathan Schonsheck who wrote (4073)	1/14/1999 6:37:00 PM
From: John H. Farro	Read Replies (2) \| Respond to of 4342

Jonathan, Thanks for posting this. Here is my favorite sentence of the release: ''We fully expect revenues to continue flowing, not only from the BioFIT program, but also from our initiatives in our Environmental* and Drug Development business segments,'' he concluded."* This seems like a strong hint that we could see a deal on the Ah ImmunoAssay in the not too distant future. Of course I would like to have seen this go up more today, but the news was released late in the afternoon and it's hard to fight a market plummeting over 200 points. I've been made to look like a fool so many times by the stock price, but I bet if we will finally reach $2 if we see a good deal on the Ah ImmunoAssay. Robin